BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29765153)

  • 1. COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer.
    Garg R; Blando JM; Perez CJ; Lal P; Feldman MD; Smyth EM; Ricciotti E; Grosser T; Benavides F; Kazanietz MG
    Oncogene; 2018 Aug; 37(34):4735-4749. PubMed ID: 29765153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Kinase C Epsilon Cooperates with PTEN Loss for Prostate Tumorigenesis through the CXCL13-CXCR5 Pathway.
    Garg R; Blando JM; Perez CJ; Abba MC; Benavides F; Kazanietz MG
    Cell Rep; 2017 Apr; 19(2):375-388. PubMed ID: 28402859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinoma.
    Hafeez BB; Zhong W; Weichert J; Dreckschmidt NE; Jamal MS; Verma AK
    Cancer Res; 2011 Mar; 71(6):2318-27. PubMed ID: 21406403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of nuclear factor κB (NF-κB) in prostate cancer is mediated by protein kinase C epsilon (PKCepsilon).
    Garg R; Blando J; Perez CJ; Wang H; Benavides FJ; Kazanietz MG
    J Biol Chem; 2012 Oct; 287(44):37570-82. PubMed ID: 22955280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers.
    Hafeez BB; Fischer JW; Singh A; Zhong W; Mustafa A; Meske L; Sheikhani MO; Verma AK
    Cancer Prev Res (Phila); 2015 May; 8(5):375-86. PubMed ID: 25627799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
    Aziz MH; Manoharan HT; Church DR; Dreckschmidt NE; Zhong W; Oberley TD; Wilding G; Verma AK
    Cancer Res; 2007 Sep; 67(18):8828-38. PubMed ID: 17875724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-specific conditional PKCε knockout mice: a model to precisely reveal PKCε functional role in initiation, promotion and progression of cancer.
    Hafeez BB; Meske L; Singh A; Singh A; Zhong W; Powers P; John M; Griep AE; Verma AK
    Oncotarget; 2016 May; 7(22):33069-80. PubMed ID: 27102301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic overexpression of PKCε in the mouse prostate induces preneoplastic lesions.
    Benavides F; Blando J; Perez CJ; Garg R; Conti CJ; DiGiovanni J; Kazanietz MG
    Cell Cycle; 2011 Jan; 10(2):268-77. PubMed ID: 21224724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PKCε Is an Essential Mediator of Prostate Cancer Bone Metastasis.
    Gutierrez-Uzquiza A; Lopez-Haber C; Jernigan DL; Fatatis A; Kazanietz MG
    Mol Cancer Res; 2015 Sep; 13(9):1336-46. PubMed ID: 26023164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of prostate cancer cell survival by protein kinase Cepsilon involves bad phosphorylation and modulation of the TNFalpha/JNK pathway.
    Meshki J; Caino MC; von Burstin VA; Griner E; Kazanietz MG
    J Biol Chem; 2010 Aug; 285(34):26033-40. PubMed ID: 20566643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C epsilon promotes de novo lipogenesis and tumor growth in prostate cancer cells by regulating the phosphorylation and nuclear translocation of pyruvate kinase isoform M2.
    Lai X; Liang Y; Jin J; Zhang H; Wu Z; Li G; Wang J; Zhang Z; Chen H; Zeng F; Deng F
    Exp Cell Res; 2023 Jan; 422(1):113427. PubMed ID: 36400183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk of protein kinase C ε with Smad2/3 promotes tumor cell proliferation in prostate cancer cells by enhancing aerobic glycolysis.
    Xu W; Zeng F; Li S; Li G; Lai X; Wang QJ; Deng F
    Cell Mol Life Sci; 2018 Dec; 75(24):4583-4598. PubMed ID: 30209539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition.
    El Bezawy R; Tinelli S; Tortoreto M; Doldi V; Zuco V; Folini M; Stucchi C; Rancati T; Valdagni R; Gandellini P; Zaffaroni N
    J Exp Clin Cancer Res; 2019 Feb; 38(1):51. PubMed ID: 30717752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-tomatine attenuation of in vivo growth of subcutaneous and orthotopic xenograft tumors of human prostate carcinoma PC-3 cells is accompanied by inactivation of nuclear factor-kappa B signaling.
    Lee ST; Wong PF; He H; Hooper JD; Mustafa MR
    PLoS One; 2013; 8(2):e57708. PubMed ID: 23437404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
    Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
    Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase Cε-calcineurin cosignaling downstream of toll-like receptor 4 downregulates fibrosis and induces wound healing gene expression in cardiac myofibroblasts.
    Mesquita RF; Paul MA; Valmaseda A; Francois A; Jabr R; Anjum S; Marber MS; Budhram-Mahadeo V; Heads RJ
    Mol Cell Biol; 2014 Feb; 34(4):574-94. PubMed ID: 24298017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of 5-lipoxygenase triggers apoptosis in prostate cancer cells via down-regulation of protein kinase C-epsilon.
    Sarveswaran S; Thamilselvan V; Brodie C; Ghosh J
    Biochim Biophys Acta; 2011 Dec; 1813(12):2108-17. PubMed ID: 21824498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner.
    Mahadevan NR; Rodvold J; Almanza G; Pérez AF; Wheeler MC; Zanetti M
    BMC Cancer; 2011 Jun; 11():229. PubMed ID: 21649922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin signaling links protein kinase Cepsilon to the protein kinase B/Akt survival pathway in recurrent prostate cancer cells.
    Wu D; Thakore CU; Wescott GG; McCubrey JA; Terrian DM
    Oncogene; 2004 Nov; 23(53):8659-72. PubMed ID: 15467757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.
    Yang W; Xia Y; Cao Y; Zheng Y; Bu W; Zhang L; You MJ; Koh MY; Cote G; Aldape K; Li Y; Verma IM; Chiao PJ; Lu Z
    Mol Cell; 2012 Dec; 48(5):771-84. PubMed ID: 23123196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.